Serum interleukin 38 (IL-38) as a new potential biomarker of pediatric asthma
Autor: | Asmaa Kamal, Christine W. S. Basanti, Mahmoud A. Kaushty, Azza K. Abdelmegeid |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | The Egyptian Journal of Bronchology, Vol 16, Iss 1, Pp 1-10 (2022) |
Druh dokumentu: | article |
ISSN: | 1687-8426 2314-8551 |
DOI: | 10.1186/s43168-022-00139-5 |
Popis: | Abstract Background Bronchial asthma is considered the most prevalent chronic respiratory disease worldwide and is one of the main causes of hospitalization in the pediatric population. Serum interleukin 38 (IL-38) levels are elevated in several inflammatory and autoimmune diseases. However, its exact role in the pathogenesis of these diseases is unclear. Objectives To investigate the role of IL-38 as a potential biomarker in pediatric patients with bronchial asthma. Methods Serum IL-38 levels were measured in 73 pediatric patients with bronchial asthma (34 atopic and 39 non-atopic) and 30 age- and sex-matched healthy control subjects using enzyme-linked immunosorbent assay. Results Serum IL-38 levels were significantly higher in patients with bronchial asthma compared to the control group (p < 0.001). A significant negative correlation was found between serum IL-38 levels and both relative and absolute eosinophilic counts in the atopic group (R = −0.575, p < 0.001 and R = −0.474, p = 0.005, respectively). Conclusion IL-38 could be a useful prognostic and therapeutic biomarker of atopic asthma in pediatric patients. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |